tradingkey.logo
tradingkey.logo
Search

Ligand Pharmaceuticals Inc

LGND
Add to Watchlist
284.430USD
-0.040-0.01%
Market hours 09/14, 13:50ET
5.67BMarket Cap
37.07P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.01%

5 Days

-0.41%

1 Month

-1.52%

6 Months

+40.18%

Year to Date

+50.44%

1 Year

+71.60%

Key Figures

284.465Open
285.450High
1.20KVolume
37.07P/E TTM
22.23P/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
284.470Prev. Close
282.715Low
341.08KTurnover
LossP/E Static
5.86P/B
0.00%Div Yield TTM
12.60%ROA
326.63052wk High
0.01Volume Ratio
-4.03MNet Profit
19.92MShares
7.6734EPS TTM
1.23Beta
17.13%ROE
161.82052wk Low
0.96%Amplitude
80.35%Gross Margin
5.67BMarket Cap
0.11Reward/Risk
2.28%Risk Rate
More news coming soon, stay tuned...

Ligand Pharmaceuticals Inc's Score

-0.12vs previous score
Forecast8.89
Financial Health9.42
Technical2.51
Valuation Dimensions6.68
Institutional Confidence10.00
Risk Assessment7.86

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
Strong BuyCurrent Rating
342.818Target Price
+20.51%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy43343332
Buy55555555
Hold00000000
Sell00000000
Strong Sell00000000

Ligand Pharmaceuticals Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Sell

Moving Average

Sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
2.42/1.84
Revenue / Forecast
63.69M/60.76M

Ligand Pharmaceuticals Inc Profile

SectorPharmaceuticals
Ticker SymbolLGND
Number of employees68
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.13.37%
Vanguard Portfolio Management, LLC5.49%
Janus Henderson Investors4.97%
Vanguard Capital Management, LLC4.23%
Shareholder TypesProportion
Investment Advisor58.25%
Investment Advisor/Hedge Fund39.07%
Research Firm3.67%
Individual Investor2.39%

FAQs

What is the current price of Ligand Pharmaceuticals Inc (LGND)?

The current price of Ligand Pharmaceuticals Inc (LGND) is 284.47.

What is the symbol of Ligand Pharmaceuticals Inc?

The ticker symbol of Ligand Pharmaceuticals Inc is LGND.

What is the 52-week high of Ligand Pharmaceuticals Inc?

The 52-week high of Ligand Pharmaceuticals Inc is 326.63.

What is the 52-week low of Ligand Pharmaceuticals Inc?

The 52-week low of Ligand Pharmaceuticals Inc is 161.82.

What is the market capitalization of Ligand Pharmaceuticals Inc?

The market capitalization of Ligand Pharmaceuticals Inc is 5.67B.

Is Ligand Pharmaceuticals Inc (LGND) currently rated as Buy, Hold, or Sell?

According to analysts, Ligand Pharmaceuticals Inc (LGND) has an overall rating of STRONG BUY, with a price target of 342.82.

What is the Earnings Per Share (EPS TTM) of Ligand Pharmaceuticals Inc (LGND)?

The Earnings Per Share (EPS TTM) of Ligand Pharmaceuticals Inc (LGND) is 7.67.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.